Image For Activity Cover
Three or One Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus- Eluting Stent Implantation (JACC Cardiovascular Interventions September 2021)
Current generation drug-eluting stents are preferred over bare-metal stents for HBR patients, but their optimal DAPT management remains unknown.


JACC: Cardiovascular Interventions Editor-in-Chief

David J. Moliterno, MD, FACC

JACC: Cardiovascular Interventions CME/MOC/ECME Editor

Michael C. McDaniel, MD


Roxana Mehran, MD
Davide Cao, MD
Karine Ruster, PhD
Jin Wang, PhD
Marco Valgimigli, MD, PhD

Important Dates

Date of Release: September 6, 2021
Term of Approval/Date of CME/MOC/ECME Expiration: September 5, 2022

Availability: Retired
Cost: FREE
Credit Offered:
No Credit Offered
Android App Download IOS App Download Powered By